1. Home
  2. KRNT vs GERN Comparison

KRNT vs GERN Comparison

Compare KRNT & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNT
  • GERN
  • Stock Information
  • Founded
  • KRNT 2002
  • GERN 1990
  • Country
  • KRNT Israel
  • GERN United States
  • Employees
  • KRNT N/A
  • GERN N/A
  • Industry
  • KRNT Industrial Machinery/Components
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRNT Industrials
  • GERN Health Care
  • Exchange
  • KRNT Nasdaq
  • GERN Nasdaq
  • Market Cap
  • KRNT 875.0M
  • GERN 974.5M
  • IPO Year
  • KRNT 2015
  • GERN 1996
  • Fundamental
  • Price
  • KRNT $20.00
  • GERN $1.41
  • Analyst Decision
  • KRNT Strong Buy
  • GERN Buy
  • Analyst Count
  • KRNT 5
  • GERN 7
  • Target Price
  • KRNT $33.20
  • GERN $4.17
  • AVG Volume (30 Days)
  • KRNT 267.1K
  • GERN 9.4M
  • Earning Date
  • KRNT 08-06-2025
  • GERN 08-07-2025
  • Dividend Yield
  • KRNT N/A
  • GERN N/A
  • EPS Growth
  • KRNT N/A
  • GERN N/A
  • EPS
  • KRNT N/A
  • GERN N/A
  • Revenue
  • KRNT $206,506,000.00
  • GERN $116,293,000.00
  • Revenue This Year
  • KRNT $10.86
  • GERN $160.12
  • Revenue Next Year
  • KRNT $12.68
  • GERN $55.01
  • P/E Ratio
  • KRNT N/A
  • GERN N/A
  • Revenue Growth
  • KRNT N/A
  • GERN 22264.04
  • 52 Week Low
  • KRNT $13.59
  • GERN $1.17
  • 52 Week High
  • KRNT $34.29
  • GERN $5.06
  • Technical
  • Relative Strength Index (RSI)
  • KRNT 48.11
  • GERN 46.12
  • Support Level
  • KRNT $19.54
  • GERN $1.34
  • Resistance Level
  • KRNT $20.14
  • GERN $1.44
  • Average True Range (ATR)
  • KRNT 0.69
  • GERN 0.10
  • MACD
  • KRNT 0.04
  • GERN -0.02
  • Stochastic Oscillator
  • KRNT 80.78
  • GERN 29.17

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: